Evidence map›Paper›PMID 27904678›Full record

ArticleAmerican journal of translational research2016

miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB.

Zimin Liu, Chenghong Wang, Xuelong Jiao, Shanna Zhao, Xudong Liu, Yun Wang, Jian Zhang

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis.International journal of molecular sciences · 2018
    Review
  17. Article
  18. MicroRNA-183-5p Inhibits Aggressiveness of Cervical Cancer Cells by Targeting Integrin Subunit Beta 1 (ITGB1).Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Zimin LiuDepartment of Onocology, The Affiliated Hospital of Qingdao University Qingdao, Shandong, China.
Chenghong WangDepartment of Clinical Laboratory, Yantaishan Hospital Yantai, Shandong, China.
Xuelong JiaoDepartment of General Surgery, The Affiliated Hospital of Qingdao University Qingdao, Shandong, China.
Shanna ZhaoDepartment of Onocology, The Affiliated Hospital of Qingdao UniversityQingdao, Shandong, China; Department of Clinical Laboratory, Yantaishan HospitalYantai, Shandong, China.
Xudong LiuDepartment of Clinical Laboratory, Yantaishan Hospital Yantai, Shandong, China.
Yun WangDepartment of Clinical Laboratory, Yantaishan HospitalYantai, Shandong, China; Lab of Tumor Immunology, Department of Anatomy and Histology & Embryology, Shanghai Medical College of Fudan UniversityShanghai, China.
Jian ZhangDepartment of General Surgery, The Affiliated Hospital of Qingdao University Qingdao, Shandong, China.
Qingdao University · CNYantaishan Hospital · CNShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivemicroRNAs (miRs) are small noncoding RNAs that modulate a variety of cellular processes by regulating multiple targets, which can promote or inhibit the development of malignant behaviors. Accumulating evidence suggests that microRNA-221 (miR-221) plays important roles in human carcinogenesis. It has recently found that miR-221 was overexpressed in hepatocellular carcinoma (HCC), and overexpression of miR-221 has a bad prognosis in these patients. Thus, down-regulation of miR-221 expression in HCC would provide new treatment approaches. This study aimed to study the role of miR-221 on HCC cell growth, apoptosis, invasion and metastasis in vitro and vivo, and explored the possible mechanisms involved.

methodsEffects of miR-221 upregulation or miR-221 downregulation by miR-221 inhibitor (anti-miR-221) or miR-221 mimic (miR-221) transfection on growth, apoptosis and invasion of HepG2 cells in vitro was detected. Using p65 siRNA and p65 cDNA transfection to examine the NFκB signaling pathway. A subcutaneously implanted tumor model of HepG2 cells in nude mouse was used to assess the effects of anti-miR-221 or miR-221 overexpression on tumorigenesis development. Using an intravenously injected tumor model of HepG2 cells to assess the effects of anti-miR-221 or miR-221 overexpression on lung metastasis. The signaling pathway was analyzed in vivo.

resultsAnti-miR-221 inhibited growth, invasion and induced apoptosis of HepG2 cells in vitro. This was accompanied by concomitant attenuation of NFκB, and downregulation of NFκB downstream genes such as Bcl-2, VEGF and MMP-9. In addition, miR-221 overexpression promoted growth and invasion of HepG2 cells in vitro, and accompanied by activation of NFκB, and upregulation of NFκB downstream genes Bcl-2, VEGF and MMP-9. Targeting P65 or P65 overexpression reversed the effect of miR-221, and inhibited or induced miR-221 expression, creating a positive feedback loop in human HepG2, respectively. Morever, stable overexpression of anti-miR-221 in HepG2 cells inhibits establishment of xenografts and lung metastasis in nude mice; Stable overexpression of miR-221 in HepG2 cells promotes establishment of xenografts and lung metastasis in nude mice.

conclusionsTherapies targeting the miR-221 signaling pathway may be more effective to prevent primary tumor formation and organ metastasis. The ability of this therapy to decrease tumorigenesis and metastasis may be related to NFκB signals.

Indexed as

apoptosisHepatocellular carcinomametastasismicroRNA-221NFκB

Identifiers

PMID27904678
PMCPMC5126320
OpenAlexW2559861346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.